A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

NCT00006280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

NIH

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Tobramycin for Inhalation

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]